StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –

Novartis Scope 2 Indirect Emissions by Year

Scope 2 Indirect Emissions (Location-Based, thousand metric tons CO2e)

Novartis Scope 2 Indirect Emissions: 185 in FY2025, down 7.0% from a year earlier.

Latest, FY2025
185
Period ended Dec 31, 2025
Change on a year earlier
-7.0%
199 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below

Where the FY2025 figure comes from

“| Gross location-based Scope 2 GHG emissions | 184.7 | 198.5 |”

Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗

Reported in ESG Data Summary 2025.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedScope 2 Indirect Emissions (Location-Based, thousand metric tons CO2e)Year on yearSource
FY2025Dec 31, 2025185-7.0%Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗
FY2024Dec 31, 2024199+1.8%Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗
FY2023Dec 31, 2023195-25.0%Novartis Form 6-K (0001370368-25-000008) ↗
FY2022Dec 31, 2022260–Novartis Form 6-K (0001370368-25-000008) ↗

Cite this data

StockData. (2026). Novartis Scope 2 Indirect Emissions, annual FY2022–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/env-scope2-loc-kt

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.